査読有
doi：10.1111/hepr.70123
PubMed No.：41568574
2024 Impact Factor：3.4
種類：LETTER TO THE EDITOR
誌名：Hepatology Research
発行年月：2026年1月
巻号頁：in press
論題：Response to "Aspirin for Primary Prevention in Metabolic Dysfunction-Associated Steatotic Liver Disease"
著者：Tsubasa Tsutsumi, Michael R Charlton, Takumi Kawaguchi, Mary E Rinella
